Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 USD | +5.86% |
|
-0.15% | -86.21% |
01/07 | Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index | CI |
27/06 | PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.21% | 349M | |
+1.26% | 204B | |
+4.93% | 178B | |
+28.70% | 156B | |
+31.22% | 113B | |
+1.44% | 64.26B | |
+20.17% | 54.98B | |
-1.86% | 47.44B | |
-8.38% | 36.7B | |
-0.35% | 34.84B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $13 From $12, Maintains Equalweight Rating